Matches in Nanopublications for { ?s ?p "empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor empliciti is a slamf7 directed immunostimulatory antibody indicated in 1 1" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label "empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor empliciti is a slamf7 directed immunostimulatory antibody indicated in 1 1" assertion.